201 related articles for article (PubMed ID: 35313064)
21. RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas.
Serrano C; Romagosa C; Hernández-Losa J; Simonetti S; Valverde C; Moliné T; Somoza R; Pérez M; Vélez R; Vergés R; Domínguez R; Carles J; Ramón Y Cajal S
Cancer; 2016 Jan; 122(1):99-107. PubMed ID: 26479291
[TBL] [Abstract][Full Text] [Related]
22. Identification of B-KSR1, a novel brain-specific isoform of KSR1 that functions in neuronal signaling.
Müller J; Cacace AM; Lyons WE; McGill CB; Morrison DK
Mol Cell Biol; 2000 Aug; 20(15):5529-39. PubMed ID: 10891492
[TBL] [Abstract][Full Text] [Related]
23. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.
Gramling MW; Eischen CM
Cell Death Differ; 2012 Jul; 19(7):1220-7. PubMed ID: 22301919
[TBL] [Abstract][Full Text] [Related]
24. Tyr728 in the kinase domain of the murine kinase suppressor of RAS 1 regulates binding and activation of the mitogen-activated protein kinase kinase.
Sibilski C; Mueller T; Kollipara L; Zahedi RP; Rapp UR; Rudel T; Baljuls A
J Biol Chem; 2013 Dec; 288(49):35237-52. PubMed ID: 24158441
[TBL] [Abstract][Full Text] [Related]
25. Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.
Hu J; Yu H; Kornev AP; Zhao J; Filbert EL; Taylor SS; Shaw AS
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6067-72. PubMed ID: 21441104
[TBL] [Abstract][Full Text] [Related]
26. Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth.
Fisher KW; Das B; Kortum RL; Chaika OV; Lewis RE
Mol Cell Biol; 2011 Jun; 31(12):2453-61. PubMed ID: 21518958
[TBL] [Abstract][Full Text] [Related]
27. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
Yan F; Polk DB
Cancer Res; 2001 Feb; 61(3):963-9. PubMed ID: 11221891
[TBL] [Abstract][Full Text] [Related]
28. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.
Brennan DF; Dar AC; Hertz NT; Chao WC; Burlingame AL; Shokat KM; Barford D
Nature; 2011 Apr; 472(7343):366-9. PubMed ID: 21441910
[TBL] [Abstract][Full Text] [Related]
29. Complexity in KSR function revealed by Raf inhibitor and KSR structure studies.
McKay MM; Freeman AK; Morrison DK
Small GTPases; 2011 Sep; 2(5):276-281. PubMed ID: 22292131
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F; Bonnec G; Tardivel A; Boujard D
Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
[TBL] [Abstract][Full Text] [Related]
31. SHP2 inhibition mitigates adaptive resistance to MEK inhibitors in KRAS-mutant gastric cancer through the suppression of KSR1 activity.
Zheng W; Yang Z; Song P; Sun Y; Liu P; Yue L; Lv K; Wang X; Shen Y; Si J; Zhang X; Ke Y; Cheng H; Hu W
Cancer Lett; 2023 Feb; 555():216029. PubMed ID: 36493900
[TBL] [Abstract][Full Text] [Related]
32. KSR as a therapeutic target for Ras-dependent cancers.
Neilsen BK; Frodyma DE; Lewis RE; Fisher KW
Expert Opin Ther Targets; 2017 May; 21(5):499-509. PubMed ID: 28333549
[TBL] [Abstract][Full Text] [Related]
33. The CNK-HYP scaffolding complex promotes RAF activation by enhancing KSR-MEK interaction.
Maisonneuve P; Sahmi M; Bergeron-Labrecque F; Ma XI; Queguiner J; Arseneault G; Lefrançois M; Kurinov I; Fronzes R; Sicheri F; Therrien M
Nat Struct Mol Biol; 2024 Feb; ():. PubMed ID: 38388830
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation.
Razidlo GL; Kortum RL; Haferbier JL; Lewis RE
J Biol Chem; 2004 Nov; 279(46):47808-14. PubMed ID: 15371409
[TBL] [Abstract][Full Text] [Related]
35. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
Sugimoto T; Stewart S; Han M; Guan KL
EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
[TBL] [Abstract][Full Text] [Related]
36. Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer.
Kim JY; Welsh EA; Fang B; Bai Y; Kinose F; Eschrich SA; Koomen JM; Haura EB
Mol Cancer Res; 2016 Oct; 14(10):1019-1029. PubMed ID: 27422710
[TBL] [Abstract][Full Text] [Related]
37. A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation.
Yin X; Zafrullah M; Lee H; Haimovitz-Friedman A; Fuks Z; Kolesnick R
Cell Physiol Biochem; 2009; 24(3-4):219-30. PubMed ID: 19710537
[TBL] [Abstract][Full Text] [Related]
38. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway.
Chie L; Amar S; Kung HF; Lin MC; Chen H; Chung DL; Adler V; Ronai Z; Friedman FK; Robinson RC; Kovac C; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2000; 45(6):441-9. PubMed ID: 10854130
[TBL] [Abstract][Full Text] [Related]
39. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
40. Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway.
Vaqué JP; Navascues J; Shiio Y; Laiho M; Ajenjo N; Mauleon I; Matallanas D; Crespo P; León J
J Biol Chem; 2005 Jan; 280(2):1112-22. PubMed ID: 15528212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]